• About
    • Our Mission
    • Threat of AMR
    • Access and Appropriate Use Principles
    • Our Investors
  • Team
  • Investments
    • How We Invest
    • Our Portfolio
    • Get On Our Radar
  • News
  • Connect

Posts about Press Releases:

  • All
  • In the News
  • Press Releases
  • Media
April 24, 2024
Press Releases

AMR Action Fund Portfolio Company UTILITY Therapeutics Granted FDA approval for pivmecillinam

Read More +
April 27, 2023
Press Releases

AMR Action Fund Expands Portfolio with Two New Investments

Read More +
January 5, 2023
Press Releases

AMR Action Fund Announces Investment in BioVersys AG

Read More +
April 4, 2022
Press Releases

AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals

Read More +
February 7, 2022
Press Releases

AMR Action Fund Opens European Office

Read More +
February 1, 2022
Press Releases

AMR Action Fund Appoints Scientific Advisory Board

Read More +
September 21, 2021
Press Releases

The AMR Action Fund Appoints Bill Burns as Board Chair

Read More +
July 15, 2021
Press Releases

The AMR Action Fund Appoints John H. Rex, MD as Chair of its Scientific Advisory Board

Read More +
Previous page Next page
contact-bg-img

Connect With Us

Contact
footer_logo

Enabling
Breakthroughs in
Antimicrobials

Stay connected

Stay up-to-date on our work to bring 2 to 4 new antibiotics to patients by the end of the decade. When we have news, we will let you know.

  • About
  • Team
  • Latest
  • Threat of AMR
  • Connect
  • Investments
  • Japan Disclaimer
  • Privacy Policy